Standout Papers

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised p... 2014 2026 2018 2022 420
  1. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (2014)
    Amit M. Oza, David Cibula et al. The Lancet Oncology
  2. Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial (2016)
    J.F.R. Robertson, Igor Bondarenko et al. The Lancet

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
Fluorescent Probes for Disease Diagnosis
2024 Standout
7 intermediate papers

Works of Jacqui Rowbottom being referenced

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
2015
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
2014 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Jacqui Rowbottom 1200 766 267 561 14 1.6k
L Rhoda Molife 846 414 182 817 43 1.6k
Tsveta Milenkova 986 894 215 460 30 1.5k
Craig P. Carden 1140 288 532 1094 18 2.1k
Christopher J. Lafargue 614 813 138 923 30 1.7k
Maha Hussain 1231 1336 69 909 19 2.2k
Jinyu Kang 1295 1358 69 768 26 2.1k
Ora Rosengarten 1428 300 461 727 32 1.9k
Maria Orr 1307 274 694 784 16 1.8k
Denka Markova 1171 498 51 607 18 1.6k
Lynda Grinsted 831 712 123 690 19 1.4k

All Works

Loading papers...

Rankless by CCL
2026